Serveur d'exploration sur la COVID en France - Analysis (France)

Index « Keywords » - entrée « Coronavirus Infections (drug therapy) »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Coronavirus Infections (diagnostic imaging) < Coronavirus Infections (drug therapy) < Coronavirus Infections (economics)  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 26.
[0-20] [0 - 20][0 - 26][20-25][20-40]
Ident.Authors (with country if any)Title
000002 (2020) Corneliu P. Popescu [Roumanie] ; Philip R. Fischer [États-Unis]Hydroxychloroquine-azithromycin for COVID-19 - Warranted or dangerous?
000003 (2020) Matthieu Million [France] ; Jean-Christophe Lagier [France] ; Philippe Gautret [France] ; Philippe Colson [France] ; Pierre-Edouard Fournier [France] ; Sophie Amrane [France] ; Marie Hocquart [France] ; Morgane Mailhe [France] ; Vera Esteves-Vieira [France] ; Barbara Doudier [France] ; Camille Aubry [France] ; Florian Correard [France] ; Audrey Giraud-Gatineau [France] ; Yanis Roussel [France] ; Cyril Berenger [France] ; Nadim Cassir [France] ; Piseth Seng [France] ; Christine Zandotti [France] ; Catherine Dhiver [France] ; Isabelle Ravaux [France] ; Christelle Tomei [France] ; Carole Eldin [France] ; Hervé Tissot-Dupont [France] ; Stéphane Honoré [France] ; Andreas Stein [France] ; Alexis Jacquier [France] ; Jean-Claude Deharo [France] ; Eric Chabrière [France] ; Anthony Levasseur [France] ; Florence Fenollar [France] ; Jean-Marc Rolain [France] ; Yolande Obadia [France] ; Philippe Brouqui [France] ; Michel Drancourt [France] ; Bernard La Scola [France] ; Philippe Parola [France] ; Didier Raoult [France]Early treatment of COVID-19 patients with hydroxychloroquine and azithromycin: A retrospective analysis of 1061 cases in Marseille, France.
000006 (2020) Philippe Gautret [France] ; Jean-Christophe Lagier [France] ; Philippe Parola [France] ; Van Thuan Hoang [Viêt Nam] ; Line Meddeb [France] ; Jacques Sevestre [France] ; Morgane Mailhe [France] ; Barbara Doudier [France] ; Camille Aubry [France] ; Sophie Amrane [France] ; Piseth Seng [France] ; Marie Hocquart [France] ; Carole Eldin [France] ; Julie Finance [France] ; Vera Esteves Vieira [France] ; Hervé Tissot Tissot-Dupont [France] ; Stéphane Honoré [France] ; Andreas Stein [France] ; Matthieu Million [France] ; Philippe Colson [France] ; Bernard La Scola [France] ; Véronique Veit [France] ; Alexis Jacquier [France] ; Jean-Claude Deharo [France] ; Michel Drancourt [France] ; Pierre Edouard Fournier [France] ; Jean-Marc Rolain [France] ; Philippe Brouqui [France] ; Didier Raoult [France]Clinical and microbiological effect of a combination of hydroxychloroquine and azithromycin in 80 COVID-19 patients with at least a six-day follow up: A pilot observational study.
000012 (2020) Jean-Luc Cracowski [France] ; Mathieu Molimard [France] ; Vincent Richard [France]Ultrafast response of the French Society of Pharmacology and Therapeutics to the COVID-19 pandemic.
000014 (2020) Lucie Pothen [Belgique] ; Halil Yildiz [Belgique] ; Julien De Greef [Belgique] ; Andrea Penaloza [Belgique] ; Christophe Beauloye [Belgique] ; Leila Belkhir [Belgique] ; Jean Cyr Yombi [Belgique]Safe use of hydroxychloroquine and its combination with azithromycin in the context of Sars-CoV-2 outbreak: Clinical experience in a Belgian tertiary center.
000017 (2020) François Montastruc [France] ; Charles Romano [France] ; Jean-Louis Montastruc [France] ; Stein Silva [France] ; Thierry Seguin [France] ; Vincent Minville [France] ; Bernard Georges [France] ; Béatrice Riu-Poulenc [France] ; Olivier Fourcade [France]Pharmacological characteristics of patients infected with SARS-Cov-2 admitted to Intensive Care Unit in South of France.
000018 (2020) Jean-Christophe Lagier [France] ; Matthieu Million [France] ; Philippe Gautret [France] ; Philippe Colson [France] ; Sébastien Cortaredona [France] ; Audrey Giraud-Gatineau [France] ; Stéphane Honoré [France] ; Jean-Yves Gaubert [France] ; Pierre-Edouard Fournier [France] ; Hervé Tissot-Dupont [France] ; Eric Chabrière [France] ; Andreas Stein [France] ; Jean-Claude Deharo [France] ; Florence Fenollar [France] ; Jean-Marc Rolain [France] ; Yolande Obadia [France] ; Alexis Jacquier [France] ; Bernard La Scola [France] ; Philippe Brouqui [France] ; Michel Drancourt [France] ; Philippe Parola [France] ; Didier Raoult [France]Outcomes of 3,737 COVID-19 patients treated with hydroxychloroquine/azithromycin and other regimens in Marseille, France: A retrospective analysis.
000019 (2020) Joëlle Micallef [France] ; Thomas Soeiro [France] ; Annie-Pierre Jonville-Béra [France]Non-steroidal anti-inflammatory drugs, pharmacology, and COVID-19 infection.
000020 (2020) David Lebeaux [France] ; Matthieu Revest [France]No evidence of clinical benefits of early treatment of COVID-19 patients with hydroxychloroquine and azithromycin: Comment on "Early treatment of COVID-19 patients with hydroxychloroquine and azithromycin: A retrospective analysis of 1061 cases in Marseille, France".
000022 (2020) Alexandre Gérard [France] ; Serena Romani [France] ; Audrey Fresse [France] ; Delphine Viard [France] ; Nadège Parassol [France] ; Aurélie Granvuillemin [France] ; Laurent Chouchana [France] ; Fanny Rocher [France] ; Milou-Daniel Drici [France]"Off-label" use of hydroxychloroquine, azithromycin, lopinavir-ritonavir and chloroquine in COVID-19: A survey of cardiac adverse drug reactions by the French Network of Pharmacovigilance Centers.
000027 (2020) M. Plaze [France] ; D. Attali [France] ; A-C Petit [France] ; M. Blatzer [France] ; E. Simon-Loriere [France] ; F. Vinckier [France] ; A. Cachia [France] ; F. Chrétien [France] ; R. Gaillard [France][Repurposing of chlorpromazine in COVID-19 treatment: the reCoVery study].
000030 (2020) L. Boyer [France] ; P. Auquier [France] ; G. Fond [France][Real-life data and Covid-19: The third avenue of reseach].
000036 (2020) H. Javelot [France] ; P-M Llorca [France] ; D. Drapier [France] ; E. Fakra [France] ; C. Hingray [France] ; G. Meyer [France] ; S. Dizet [France] ; A. Egron [France] ; C. Straczek [France] ; M. Roser [France] ; M. Masson [France] ; R. Gaillard [France] ; P. Fossati [France] ; E. Haffen [France][Informations on psychotropics and their adaptations for patients suffering from mental disorders in France during the SARS-CoV-2 epidemic].
000063 (2020) Julien Nahum [France] ; Tristan Morichau-Beauchant [France] ; Fabrice Daviaud [France] ; Perrine Echegut [France] ; Jérôme Fichet [France] ; Jean-Michel Maillet [France] ; Stéphane Thierry [France]Venous Thrombosis Among Critically Ill Patients With Coronavirus Disease 2019 (COVID-19).
000067 (2020) T. Klopfenstein [France] ; S. Zayet [France] ; A. Lohse [France] ; J-C Balblanc [France] ; J. Badie [France] ; P-Y Royer [France] ; L. Toko [France] ; C. Mezher [France] ; N J Kadiane-Oussou [France] ; M. Bossert [France] ; A-M Bozgan [France] ; A. Charpentier [France] ; M-F Roux [France] ; R. Contreras [France] ; I. Mazurier [France] ; P. Dussert [France] ; V. Gendrin [France] ; T. Conrozier [France]Tocilizumab therapy reduced intensive care unit admissions and/or mortality in COVID-19 patients.
000075 (2020) François Danion [France] ; Yvon Ruch [France] ; Marion Fourtage [France] ; Charlotte Kaeuffer [France] ; Valentin Greigert [France] ; Nicolas Lefebvre [France] ; Joris Muller [France] ; Thierry Nai [France] ; Yves Hansmann [France]The Good, the Bad, and the Hoax: When Publication Instantaneously Impacts Treatment Strategies for COVID-19.
000091 (2020) M. Plaze [France] ; D. Attali [France] ; A-C Petit [France] ; M. Blatzer [France] ; E. Simon-Loriere [France] ; F. Vinckier [France] ; A. Cachia [France] ; F. Chrétien [France] ; R. Gaillard [France]Repurposing chlorpromazine to treat COVID-19: The reCoVery study.
000139 (2020) Philippe Giaime [France] ; Maxime Guenoun [France] ; Nathalie Pedinielli [France] ; Hervé Narbonne [France] ; Jean-Philippe Bergounioux [France] ; Caroline Solas [France] ; Romain Guilhaumou [France] ; Jérôme Sampol [France] ; Jacques Ollier [France] ; Hélène Sichez [France] ; Marianne Serveaux [France] ; Flora Brunner [France] ; Stanislas Bataille [France]Hydroxychloroquine and azithromycin tolerance in haemodialysis patients during COVID-19 infection.
000140 (2020) Alice Fanin [Italie] ; Jessica Calegari [Italie] ; Anna Beverina [Italie] ; Silvia Tiraboschi [Italie]Hydroxychloroquine and azithromycin as a treatment of COVID-19.
000142 (2020) Jean-François Llitjos [France] ; Maxime Leclerc [France] ; Camille Chochois [France] ; Jean-Michel Monsallier [France] ; Michel Ramakers [France] ; Malika Auvray [France] ; Karim Merouani [France]High incidence of venous thromboembolic events in anticoagulated severe COVID-19 patients.
000147 (2020) G. Solé [France] ; E. Salort-Campana [France] ; Y. Pereon [France] ; T. Stojkovic [France] ; K. Wahbi [France] ; P. Cintas [France] ; D. Adams [France] ; P. Laforet [France] ; V. Tiffreau [France] ; I. Desguerre [France] ; L I Pisella [France] ; A. Molon [France] ; S. Attarian [France]Guidance for the care of neuromuscular patients during the COVID-19 pandemic outbreak from the French Rare Health Care for Neuromuscular Diseases Network.

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/CovidFranceV1/Data/France/Analysis
HfdIndexSelect -h $EXPLOR_AREA/Data/France/Analysis/KwdEn.i -k "Coronavirus Infections (drug therapy)" 
HfdIndexSelect -h $EXPLOR_AREA/Data/France/Analysis/KwdEn.i  \
                -Sk "Coronavirus Infections (drug therapy)" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/France/Analysis/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    CovidFranceV1
   |flux=    France
   |étape=   Analysis
   |type=    indexItem
   |index=    KwdEn.i
   |clé=    Coronavirus Infections (drug therapy)
}}

Wicri

This area was generated with Dilib version V0.6.37.
Data generation: Tue Oct 6 23:31:36 2020. Site generation: Fri Feb 12 22:48:37 2021